Morning Blend

Actions

Biohaven Pharmaceuticals | 10/24/22

Posted
and last updated

OCD Advocate Ethan Smith and Dr. John Sonnenberg sat down to discuss obsessive-compulsive disorder and an investigational drug that will treat symptoms. This drug is being made by Biohaven Pharmaceuticals.

This segment is paid for by Biohaven Pharmaceuticals.